Skip to main content
Top
Published in: Journal of Gastroenterology 12/2010

01-12-2010 | Original Article—Liver, Pancreas, and Biliary Tract

Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease

Authors: Tomoko Hatta, Yasunari Fujinaga, Masumi Kadoya, Hitoshi Ueda, Hiroaki Murayama, Masahiro Kurozumi, Kazuhiko Ueda, Michiharu Komatsu, Tadanobu Nagaya, Satoru Joshita, Ryo Kodama, Eiji Tanaka, Tsuyoshi Uehara, Kenji Sano, Naoki Tanaka

Published in: Journal of Gastroenterology | Issue 12/2010

Login to get access

Abstract

Background

To assess the degree of hepatic fat content, simple and noninvasive methods with high objectivity and reproducibility are required. Magnetic resonance imaging (MRI) is one such candidate, although its accuracy remains unclear. We aimed to validate an MRI method for quantifying hepatic fat content by calibrating MRI reading with a phantom and comparing MRI measurements in human subjects with estimates of liver fat content in liver biopsy specimens.

Methods

The MRI method was performed by a combination of MRI calibration using a phantom and double-echo chemical shift gradient-echo sequence (double-echo fast low-angle shot sequence) that has been widely used on a 1.5-T scanner. Liver fat content in patients with nonalcoholic fatty liver disease (NAFLD, n = 26) was derived from a calibration curve generated by scanning the phantom. Liver fat was also estimated by optical image analysis. The correlation between the MRI measurements and liver histology findings was examined prospectively.

Results

Magnetic resonance imaging measurements showed a strong correlation with liver fat content estimated from the results of light microscopic examination (correlation coefficient 0.91, P < 0.001) regardless of the degree of hepatic steatosis. Moreover, the severity of lobular inflammation or fibrosis did not influence the MRI measurements.

Conclusions

This MRI method is simple and noninvasive, has excellent ability to quantify hepatic fat content even in NAFLD patients with mild steatosis or advanced fibrosis, and can be performed easily without special devices.
Literature
1.
go back to reference Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21:17–26.CrossRefPubMed Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21:17–26.CrossRefPubMed
2.
go back to reference Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–57.CrossRefPubMed Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–57.CrossRefPubMed
3.
go back to reference Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–25.CrossRefPubMed Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–25.CrossRefPubMed
4.
go back to reference Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960–7.CrossRefPubMed Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960–7.CrossRefPubMed
5.
go back to reference Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.CrossRefPubMed Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.CrossRefPubMed
6.
go back to reference Nonomura A, Enomoto Y, Takeda M, Tamura T, Kasai T, Yoshikawa T, et al. Clinical and pathological features of non-alcoholic steatohepatitis. Hepatol Res. 2005;33:116–21.CrossRefPubMed Nonomura A, Enomoto Y, Takeda M, Tamura T, Kasai T, Yoshikawa T, et al. Clinical and pathological features of non-alcoholic steatohepatitis. Hepatol Res. 2005;33:116–21.CrossRefPubMed
7.
go back to reference Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–9.CrossRefPubMed Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–9.CrossRefPubMed
8.
go back to reference Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.CrossRefPubMed Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.CrossRefPubMed
10.
go back to reference Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108–13.CrossRefPubMed Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108–13.CrossRefPubMed
11.
go back to reference Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–50.CrossRefPubMed Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–50.CrossRefPubMed
12.
go back to reference Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189–94.PubMed Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189–94.PubMed
13.
go back to reference Lee JK, Dixon WT, Ling D, Levitt RG, Murphy WA. Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Radiology. 1984;153:195–201.PubMed Lee JK, Dixon WT, Ling D, Levitt RG, Murphy WA. Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Radiology. 1984;153:195–201.PubMed
14.
go back to reference Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging. 1997;15:287–93.CrossRefPubMed Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging. 1997;15:287–93.CrossRefPubMed
15.
go back to reference Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A. Fat suppression in MR imaging: techniques and pitfalls. Radiographics. 1999;19:373–82.PubMed Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A. Fat suppression in MR imaging: techniques and pitfalls. Radiographics. 1999;19:373–82.PubMed
16.
go back to reference Mitchell DG, Kim I, Chang TS, Vinitski S, Consigny PM, Saponaro SA, et al. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol. 1991;26:1041–52.CrossRefPubMed Mitchell DG, Kim I, Chang TS, Vinitski S, Consigny PM, Saponaro SA, et al. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol. 1991;26:1041–52.CrossRefPubMed
17.
go back to reference Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, et al. Fatty infiltration of the liver: quantification with phase contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol. 1991;156:307–12.PubMed Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, et al. Fatty infiltration of the liver: quantification with phase contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol. 1991;156:307–12.PubMed
18.
go back to reference Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Makita O, Kadota M, et al. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. Radiology. 2001;218:642–6.PubMed Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Makita O, Kadota M, et al. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. Radiology. 2001;218:642–6.PubMed
19.
go back to reference Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl. 2003;9:851–6.CrossRefPubMed Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl. 2003;9:851–6.CrossRefPubMed
20.
go back to reference Pilleul F, Chave G, Dumortier J, Scoazec JY, Valette PJ. Fatty infiltration of the liver: detection and grading using dual T1 gradient echo sequences on clinical MR system. Gastroenterol Clin Biol. 2005;29:1143–7.CrossRefPubMed Pilleul F, Chave G, Dumortier J, Scoazec JY, Valette PJ. Fatty infiltration of the liver: detection and grading using dual T1 gradient echo sequences on clinical MR system. Gastroenterol Clin Biol. 2005;29:1143–7.CrossRefPubMed
21.
go back to reference Schuchmann S, Weigel C, Albrecht L, Kirsch M, Lemke A, Lorenz G, et al. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5, 3.0 T MR imaging. Eur J Radiol. 2007;62:416–22.CrossRefPubMed Schuchmann S, Weigel C, Albrecht L, Kirsch M, Lemke A, Lorenz G, et al. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5, 3.0 T MR imaging. Eur J Radiol. 2007;62:416–22.CrossRefPubMed
22.
go back to reference Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna B, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology. 2005;237:1048–55.CrossRefPubMed Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna B, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology. 2005;237:1048–55.CrossRefPubMed
23.
go back to reference Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging—correlation with histopathologic findings. Radiology. 2006;240:116–29.CrossRefPubMed Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging—correlation with histopathologic findings. Radiology. 2006;240:116–29.CrossRefPubMed
24.
go back to reference The Examination Committee of Criteria for ‘Obesity Diseases’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘Obesity Disease’ in Japan. Circ J. 2002;66:987–92. The Examination Committee of Criteria for ‘Obesity Diseases’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘Obesity Disease’ in Japan. Circ J. 2002;66:987–92.
25.
go back to reference Tanaka N, Ichijo T, Okiyama W, Mutou H, Misawa N, Matsumoto A, et al. Laparoscopic findings in patients with nonalcoholic steatohepatitis. Liver Int. 2006;26:32–8.CrossRefPubMed Tanaka N, Ichijo T, Okiyama W, Mutou H, Misawa N, Matsumoto A, et al. Laparoscopic findings in patients with nonalcoholic steatohepatitis. Liver Int. 2006;26:32–8.CrossRefPubMed
26.
go back to reference Tanaka N, Tanaka E, Sheena Y, Komatsu M, Okiyama W, Misawa N, et al. Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population. Liver Int. 2006;26:956–63.CrossRefPubMed Tanaka N, Tanaka E, Sheena Y, Komatsu M, Okiyama W, Misawa N, et al. Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population. Liver Int. 2006;26:956–63.CrossRefPubMed
27.
go back to reference Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly-purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42:413–8.CrossRefPubMed Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly-purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42:413–8.CrossRefPubMed
28.
go back to reference Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. 2nd ed. Edinburgh: Churchill Livingstone; 1987. Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. 2nd ed. Edinburgh: Churchill Livingstone; 1987.
29.
go back to reference Szczepaniak LS, Babcock EE, Schick FD, Garg A, Dobbins RL, Burns T, et al. Measurement of intracellular triglyceride stores by H spectroscopy and validation in vivo. Am J Physiol. 1999;276:E977–89.PubMed Szczepaniak LS, Babcock EE, Schick FD, Garg A, Dobbins RL, Burns T, et al. Measurement of intracellular triglyceride stores by H spectroscopy and validation in vivo. Am J Physiol. 1999;276:E977–89.PubMed
30.
go back to reference Longo R, Pllesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human steatosis. J Magn Reson Imaging. 1995;5:281–5.CrossRefPubMed Longo R, Pllesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human steatosis. J Magn Reson Imaging. 1995;5:281–5.CrossRefPubMed
31.
go back to reference Lodes CC, Felmlee JP, Ehman RL, Sehgal CM, Greenleaf JF, Glover GH, et al. Proton MR chemical shift imaging using double and triple phase contrast acquisition methods. J Comput Assist Tomogr. 1989;13:855–61.CrossRefPubMed Lodes CC, Felmlee JP, Ehman RL, Sehgal CM, Greenleaf JF, Glover GH, et al. Proton MR chemical shift imaging using double and triple phase contrast acquisition methods. J Comput Assist Tomogr. 1989;13:855–61.CrossRefPubMed
32.
go back to reference Szumowski J, Coshow WR, Li F, Quinn SF. Phase unwrapping in the three-point Dixon method for fat suppression MR imaging. Radiology. 1994;192:555–61.PubMed Szumowski J, Coshow WR, Li F, Quinn SF. Phase unwrapping in the three-point Dixon method for fat suppression MR imaging. Radiology. 1994;192:555–61.PubMed
33.
go back to reference Cotler SJ, Guzman G, Layden-Almer J, Mazzone T, Layden TJ, Zhou XJ. Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging. 2007;25:743–8.CrossRefPubMed Cotler SJ, Guzman G, Layden-Almer J, Mazzone T, Layden TJ, Zhou XJ. Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging. 2007;25:743–8.CrossRefPubMed
34.
go back to reference Westphalen AC, Qayyum A, Yeh BM, Merriman RB, Lee JA, Lamba A, et al. Liver fat: effect of hepatic iron deposit on evaluation with opposed-phase MR imaging. Radiology. 2007;242:450–5.CrossRefPubMed Westphalen AC, Qayyum A, Yeh BM, Merriman RB, Lee JA, Lamba A, et al. Liver fat: effect of hepatic iron deposit on evaluation with opposed-phase MR imaging. Radiology. 2007;242:450–5.CrossRefPubMed
35.
go back to reference Iijima H, Moriyasu F, Tsuchiya K, Suzuki S, Yoshida M, Shimizu M, et al. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res. 2007;37:722–30.CrossRefPubMed Iijima H, Moriyasu F, Tsuchiya K, Suzuki S, Yoshida M, Shimizu M, et al. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res. 2007;37:722–30.CrossRefPubMed
Metadata
Title
Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease
Authors
Tomoko Hatta
Yasunari Fujinaga
Masumi Kadoya
Hitoshi Ueda
Hiroaki Murayama
Masahiro Kurozumi
Kazuhiko Ueda
Michiharu Komatsu
Tadanobu Nagaya
Satoru Joshita
Ryo Kodama
Eiji Tanaka
Tsuyoshi Uehara
Kenji Sano
Naoki Tanaka
Publication date
01-12-2010
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 12/2010
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-010-0277-6

Other articles of this Issue 12/2010

Journal of Gastroenterology 12/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.